Last reviewed · How we verify
NCT07191106: APIMICI
Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)
NA trial testing adapted physical activity in Inflammatory Bowel Disease (IBD) in 72 participants. Currently enrolling.
30 October 2025
Quick facts
| Lead sponsor | Raincy Montfermeil Hospital Group |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 72 |
| Start date | 15 September 2025 |
| Primary completion | 30 October 2025 |
| Estimated completion | 31 March 2026 |
| Sites | 2 locations across France |
Drugs / interventions tested
- adapted physical activity
Conditions studied
- Inflammatory Bowel Disease (IBD) — all drugs for Inflammatory Bowel Disease (IBD) →
- Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis) — all drugs for Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis) →
Sponsor
Raincy Montfermeil Hospital Group
Who can join
18 and older, any sex, with Inflammatory Bowel Disease (IBD) or Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although anti-TNFα therapies are effective in reducing disease activity and improving quality of life, they are frequently associated with side effects such as fatigue, weight gain, and joint pain, which may be mitigated by regular physical activity. Emerging evidence suggests that light to moderate physical activity may help reduce systemic and intestinal inflammation and improve IBD-related outcomes. However, access to structured physical activity programs remains limited, and personal or professional constraints may hinder participation. This pilot study aims to assess the feasibility and impact of a remotely delivered Adapted Physical Activity (APA) program on the quality of life of patients with Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis. This study evaluates the effects of a 12-weeks remote APA intervention on quality of life as the primary outcome. Secondary objectives include assessing changes in anxiety and depression, fatigue levels, IBD activity, and smoking behavior. The findings from this study may inform the development of scalable, non-pharmacological strategies to support symptom management and well-being in individuals with IBD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07191106
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of adapted physical activity
Trials testing the same drug.
- NCT07118007 — Assessment of the Benefits of Adapted Physical Activity in Pediatric Hemodialysis Patients · NA · not yet recruiting
- NCT03774329 — Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowe · NA · completed
- NCT04080063 — Biological Markers of Functional Effects of Physical Activity in an Elderly Population · NA · completed
- NCT05201417 — Adapted Physical Activity and Prevention of Cardiovascular Risk in Elderly People Living With HIV:Comparative Study · NA · completed
- NCT03829072 — Cooking Education and Adapted Physical Activity in Allografted Patients · NA · completed
Other recruiting trials for Inflammatory Bowel Disease (IBD)
Currently open trials in the same condition.
- NCT07245394 — Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD) · recruiting
- NCT07237516 — Zymfentra (Infliximab-dyyb) REal World Cohort STudy · recruiting
- NCT07224113 — Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD · recruiting
- NCT07221890 — A Trial of Academic Detailing to Promote Prescribing of Biosimilars · NA · active not recruiting
- NCT07355101 — Personalized Exercise Coaching to Improve Quality of Life in Pediatric IBD · NA · active not recruiting
Other Raincy Montfermeil Hospital Group trials
Trials by the same sponsor.
- NCT05085717 — Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children · completed
- NCT05099653 — Study of the Impact of a Physical Activity Programme on the Quality of Life of Patients With Inflammatory Bowel Disease · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07191106 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Raincy Montfermeil Hospital Group
- Last refreshed: 24 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07191106.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing